Niki BioSolutions, Inc.

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Withdrawal of a registration statement

Registration statement under Securities Act of 1933

Financial Statements and Exhibits

Financial Statements and Exhibits

Other Events

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Completion of Acquisition or Disposition of Assets

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (amendment)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement under Securities Act of 1933 (amendment)

Registration statement / Annual report / Transition report for Foreign Private Issuers

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (amendment)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement under Securities Act of 1933 (amendment)

Registration statement for securities of certain foreign private issuers

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (amendment)

Prospectus Supplement for Primary Offering

Notice of Effectiveness

No description available

Registration statement for securities of certain foreign private issuers

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Prospectus Supplement for Primary Offering

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement under Securities Act of 1933

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Draft registration statement (confidential submission)

Draft registration statement (confidential submission)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Registration statement / Annual report / Transition report for Foreign Private Issuers

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Prospectus Supplement for Primary Offering

Registration statement / Annual report / Transition report for Foreign Private Issuers

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Registration statement / Annual report / Transition report for Foreign Private Issuers

Letter from the SEC

Registration statement / Annual report / Transition report for Foreign Private Issuers (amendment)

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Registration statement / Annual report / Transition report for Foreign Private Issuers

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Registration statement / Annual report / Transition report for Foreign Private Issuers

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Registration statement / Annual report / Transition report for Foreign Private Issuers

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Letter from the SEC

Correspondence with the SEC

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Registration statement / Annual report / Transition report for Foreign Private Issuers (amendment)

Registration statement / Annual report / Transition report for Foreign Private Issuers

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Arner Douglas Wayne

Wu Justin Che Yuen

Mireskandari Alidad

Philips Laura A

Sheinerman Kira